Compounded peptides and medications
A compounded medication is prepared by a licensed pharmacy for an individual prescription rather than manufactured in a factory. It's how providers prescribe compounded peptides and other molecules that have no commercial version and adjust formulations to a patient — and it comes with its own rules: compounded medications are not FDA-approved, and quality depends on the pharmacy's standards.
These articles explain how compounding works, how it's regulated, and what that means for the treatments you're prescribed.
226 articles on this topic
-
Oral BPC-157: Do Capsules Work?
Oral activity has been reported in rat gut models, but capsules have not been tested in human trials and their absorption in people has not been measured. A capsule label cannot close that evidence gap.
-
PT-141 Side Effects: What the Trials Found
PT-141 most often causes nausea, flushing, headache, and injection-site reactions. The safety questions that change screening are blood-pressure effects, skin darkening, and how little modern evidence exists for men.
-
Telehealth Peptide Therapy: How the Process Works
Telehealth peptide therapy is a prescription-based clinical service: medical intake, provider review, pharmacy dispensing, and follow-up. The important distinction is accountability at every handoff, not simply ordering a vial online.
-
GHK-Cu Side Effects: Topical vs Injectable
GHK-Cu side effects are usually mild with topical cosmetics, but injectable GHK-Cu has no long-term human safety data. Route is the difference that matters.
-
Tesamorelin Side Effects: Rates, Risks, Monitoring
The most common tesamorelin side effects are injection-site reactions and joint pain; glucose, IGF-1 and cancer history are the monitoring issues that can change the plan.
-
Tirzepatide for Type 2 Diabetes: Trial Results
Across the SURPASS trials, adults assigned to tirzepatide had average HbA1c reductions of roughly 1.9 to 2.4 percentage points over 40 to 52 weeks. The right comparison depends on a person's existing diabetes treatment and clinical risks.
-
GLP-1 Drops: What the Absorption Evidence Shows
GLP-1 drops promise a needle-free shortcut, but the delivery system is the whole question. No published human clinical evidence yet shows that sublingual semaglutide drops achieve meaningful absorption or weight-loss efficacy.
-
Peptide Compounding Pharmacy: What It Does
A peptide compounding pharmacy prepares a prescription for a named patient when no suitable manufactured product meets that patient's need. The meaningful checks are the prescription, the facility's regulatory pathway and its controls for identity, potency and sterility.
-
CJC-1295 No DAC: What the Label Actually Means
CJC-1295 no DAC is label shorthand for modified GRF 1-29, a short-acting GHRH analog without the albumin-binding feature that makes the DAC form last for days.
-
NAD Injection Side Effects: What Is Reported
Published intravenous data describe transient infusion-associated symptoms in one small retrospective series and no reported adverse events in an earlier slow-infusion pilot; because the studies differed in design and did not randomize infusion rate, they do not establish speed as the cause.
-
Does Insurance Cover Tirzepatide? 2026 Guide
Insurance may cover Mounjaro for type 2 diabetes, while Zepbound coverage for obesity or sleep apnea depends on the plan. Compounded tirzepatide is generally self-pay.
-
Ipamorelin Side Effects: What Human Data Shows
Human safety data for ipamorelin are unusually thin. Short-term reports exist, but no published trial tells us how common side effects are with months or years of compounded use.
-
Is Tirzepatide Safe? What the Evidence Shows
Safety is not a property of the molecule. It is the dose, the source of the vial, your own medical history, and whether a licensed clinician is accountable for the decision.
-
Oral Semaglutide: How the Semaglutide Pill Works
Estimated absolute bioavailability is about 0.4% to 1% for Rybelsus tablets and about 1% to 2% for Ozempic and Wegovy tablets; all three labels require fasting administration with up to 4 ounces of water and a 30-minute wait. Promise's compounded semaglutide formulation discussed here is an injectable solution.
-
Does Sermorelin Work? What Human Studies Show
Small human studies show that sermorelin can increase growth hormone output, but IGF-1 and body-composition results are inconsistent. Whether it is working should be judged with labs and a prescriber, not a feeling or a promised calendar.
-
Is Semaglutide Safe? What the Evidence Shows
Semaglutide has years of trial data and a defined risk profile, but safe is not universal. Eligibility depends on personal history, other medicines, monitoring and exactly what product is dispensed.
-
Tirzepatide Weight Loss Results by Month
In SURMOUNT-1, average weight loss reached 15.0% to 20.9% at 72 weeks, depending on dose. The first month was only the initiation phase, and results varied widely.
-
MOTS-c Side Effects: What Is Known and What Is Not
No completed human trial has measured them. What gets sold as a MOTS-c side-effect profile is assembled from injection-site experience with subcutaneous peptides, from pharmacology, and from what a prescriber screens for.
-
Tirzepatide for Sleep Apnea: What Was Approved
In December 2024 Zepbound became the first medicine approved in the United States for moderate-to-severe obstructive sleep apnea in adults with obesity. The trials behind it are specific, and so is what that approval does and does not cover.
-
How to Check If a Telehealth Doctor Is Licensed
A license check takes only a few minutes when you use the right source. Start with the clinician's legal name, verify current authority in the state where you will attend the visit, and treat an NPI as a cross-check—not a license.
Page 10 of 12 · 226 articles